作者
Anchalee Avihingsanon, Thornthun Ueaphongsukkit, Sivaporn Gatechompol, Jiratchaya Sophonphan, Stephen J Kerr, Hay Mar Su Lwin, Sasiwimol Ubolyam, Prachya Chaiyahong, Noppadol Wacharachaisurapol, P Chaiyavilaskul, YS Cho, JG Shin
发表日期
2022/8/1
期刊
The 24th International AIDS conference
简介
Background:• Concurrent use of Rifampicin (RIF) and dolutegravir (DTG) reduce DTG exposure, thus, DTG 50 mg twice-daily is currently recommended.
引用总数
2022202322
学术搜索中的文章
A Avihingsanon, T Ueaphongsukkit, S Gatechompol… - The 24th International AIDS conference, 2022